DrugPatentWatch Database Preview
Litigation Details for WARNER CHILCOTT COMPANY, LLC v. MYLAN INC. (D.N.J. 2011)
» See Plans and Pricing
WARNER CHILCOTT COMPANY, LLC v. MYLAN INC. (D.N.J. 2011)
| Docket | Start Trial | Date Filed | 2011-11-22 |
| Court | District Court, D. New Jersey | Date Terminated | 2014-04-17 |
| Cause | 35:271 Patent Infringement | Assigned To | Mary Little Cooper |
| Jury Demand | None | Referred To | Magistrate Judge Douglas E. Ar |
| Patents | 6,667,050 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in WARNER CHILCOTT COMPANY, LLC v. MYLAN INC.
The small molecule drugs covered by the patent cited in this case are Start Trial , Start Trial , Start Trial , and Start Trial .
Details for WARNER CHILCOTT COMPANY, LLC v. MYLAN INC. (D.N.J. 2011)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2013-05-23 | 77 | contraceptive products covered by U.S. Patent No. 6,667,050 (“the ’050 patent”), Femcon® Fe (which was first …generic versions of Generess® Fe infringe the ’050 patent. Id. at 1. Critical to the instant application,…the Lupin ANDA meets the limitations of the ‘050 patent’s composition claims.” Id. Second, Lupin claims… 17 April 2014 3:11-cv-06844-MLC-DEA Patent None District Court, D. New Jersey | External link to document | |
| 2013-07-02 | 86 | Defendants”) have infringed U.S. Patent 6,667,050 (the “’050 patent”). Presently before the Court is …terms. I. BACKGROUND The ‘050 patent issued from U.S. Patent Application No. 09/879,028, filed on…to prevail in a patent infringement suit, a plaintiff must establish that the patent claim “covers the… “It is a bedrock principle of patent law that the claims of a patent define the invention to which the… District Judge. This is a Hatch-Waxman patent infringement action in which Plaintiff Warner Chilcott | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
